Can a simple blood test predict liver cancer's return?
NCT ID NCT06141564
First seen Nov 18, 2025 · Last updated Apr 28, 2026 · Updated 25 times
Summary
This study collects blood and tumor tissue from 360 early-stage liver cancer patients who had surgery to remove their cancer. Researchers look for specific immune system markers and antibodies that might signal whether the cancer will come back. The goal is to better understand why some patients have a recurrence and to guide future treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
108 Military Central Hospital
Hanoi, Vietnam
Conditions
Explore the condition pages connected to this study.